Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIs

Lung Cancer ◽  
2015 ◽  
Vol 90 (2) ◽  
pp. 261-266 ◽  
Author(s):  
Su Jin Lee ◽  
Jong-Mu Sun ◽  
Se Hoon Lee ◽  
Jin Seok Ahn ◽  
Keunchil Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Egfr Tkis

scholarly journals Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

2013 ◽  
Vol 6 (1) ◽  
pp. 139 ◽  
Author(s):  
Kanako Umekawa ◽  
Tatsuo Kimura ◽  
Shinzoh Kudoh ◽  
Tomohiro Suzumura ◽  
Takako Oka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tkis

scholarly journals MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type

Oncotarget ◽  
2014 ◽  
Vol 5 (17) ◽  
pp. 7902-7916 ◽  
Author(s):  
Jiayu Li ◽  
Xuefei Li ◽  
Shengxiang Ren ◽  
Xiaoxia Chen ◽  
Yishi Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Wild Type ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tkis
Sign in / Sign up

Export Citation Format

Share Document